<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
	<title>FourSquare Partners - Services</title>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
	<meta name="description" content="FourSquare Partners" />
	<meta name="keywords" content="medical, investment" />
	<link rel="stylesheet" href="style.css" type="text/css" />
    <style type="text/css">
<!--
.style2 {
	font-size: 1.35em;
	font-family: Georgia, "Times New Roman", Times, serif;
	color: #333333;
}
.style6 {
	color: #3399CC
}
.style12 {
	font-size: 1.30em;
	color: #3399CC;
}
.style17 {
	font-weight: bold;
	font-family: Georgia, "Times New Roman", Times, serif;
	font-style: italic;
}
.style18 {
	color: #E60000;
	font-style: italic;
}
.style21 {
	font-size: 1.3em;
	font-style: italic;
}
-->
    </style>
    <script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-9422950-2']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
</head>
<body>


	<div id="content">
<div id="logo">
			<h1><a href="index.html" class="style2"><span class="style12">F</span><span class="style6">OUR</span><span class="style12">S</span><span class="style6">QUARE</span> <span class="style12">P</span><span class="style6">ARTNERS</span></a></h1> 
	<p>four-square \-'skwa(ə)r\ adj. (14c): marked by boldness and conviction: FORTHRIGHT </p>
</div>
   <div class="quote">
   
    <div align="center"><em>&quot;Scientia potestas est&quot;<br />
  &quot;Knowledge is power&quot;</em><br /> <br />
       Francis Bacon - (1561-1626)
     </div>
     <p align="center"></div>
   
  <ul id="menu">
			<li><a href="index.html">Home</a></li>	
            <li><a class="active"  href="services.html">Services</a></li>		
			<li><a href="archive2.html">Archives</a></li>
			<li><a href="about_us.html">Profile</a></li>
            <li><a href="index.html#alert" target="_top">Alerts</a></li>
            <li><a href="http://foursquarepartners.blogspot.com/"http://foursquarepartners.blogspot.com/>essays</a></li>					
</ul>		
		<div id="main_about_us">
			
		  <h2><span class="style17">Services/Prices</span></a></h2>
<p align="justify"><img src="images/ESS at FSP 8-09_.jpg" alt="dna" width="276" height="236" id="DNA" class="dropshadow" /><strong>Since 1995, FourSquare Partners has provided buyside advice to institutional healthcare investors in the biotechnology and medical device sectors. I focus on predicting the outcomes from advanced-stage clinical trials. In general, I do not project market size, future product revenues, profitability or similar metrics. For a full Company workup, my "sweet spot" is smaller capitalization companies, less than $5.0 billion, where much of the valuation rests on the anticipated outcome of a lead product. For many of these companies, street coverage may be limited. For PIPE transactions, I provide a broad overview of the Company's prospects and, especially the Company’s historical track record to help investors better price the transaction. For most of these companies, there is no bona fide street coverage.
 <br /><br /> 
 
 <span class="style21">FourSquare provides two types of reports.</span><br />
 <br />

A <span class="style18">full Company workup</span> provides an investment conclusion (<em>long/short and timing</em>) right up front. This is followed by a brief Company background, the product's (drug or device) history and detailed coverage of the clinical development program. Most reports conclude with investment risks and merits. Additional background information may include an overview of the disease being treated, including competitive products extant. Example reports in the Archive section include Cubist, Medivation, Guilford, Lexicon and Micromet.
<br />
<br />

A so-called <span class="style18">bioquickie</span>, typically suitable for a <em>PIPE</em> transaction, is a one-to-two page overview of the Company summarizing its history - enhanced by my proprietary database, past performance and future prospects. <br />
<br />

All reports remain confidential to a single client until that client releases the report to FourSquare's archives. I have written dozens of full Company reports, most of which remain confidential. A full workup takes five-to-ten days to complete and includes communications with Company management, relevant clinicians and others as necessary. Multiple discussions with the client are encouraged and, after delivery, continued support of the investment project is provided for a nominal charge.<br /><br />

I have evaluated hundreds of biotech PIPE transactions since the late 90s. A typical project includes a brief report and, typically, a structured conversation (telephonic plus online slide-deck review) with the issuer's Management. Turnaround time includes one day to prepare for the conversation plus another day to complete the report. Client conversations are encouraged. <br /><br />

I have also worked with several firms under a <span class="style18">monthly retainer model</span> on an exclusive or semi-exclusive basis. Please inquire for more information.
</strong></p>	
	  </div>		
       
<div id="line">
  <br/>
  <div align="center"><strong>If you require independent, confidential deep due diligence for a potential biotechnology or medical technology <br /> 
    investment (financial or strategic) please contact us at (315) 963-9175 or <a href="mailto:essharps@gmail.com">essharps@gmail.com</a></strong></div>
</div>
	  <div id="footer">
	  <div id="fl">
				<p align="center" class="links">FourSquare Partners never holds a financial interest in any company covered in a recent or active report. <br />
                &copy; Copyright 2022 <strong>FourSquare Partners</strong>
				  
	  </div>	
</div>
    
    <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-9422950-2");
pageTracker._trackPageview();
} catch(err) {}</script>

<!-- Start of StatCounter Code for Dreamweaver -->
<script type="text/javascript">
var sc_project=10446551; 
var sc_invisible=1; 
var sc_security="7320d794"; 
var scJsHost = (("https:" == document.location.protocol) ?
"https://secure." : "http://www.");
document.write("<sc"+"ript type='text/javascript' src='" +
scJsHost+
"statcounter.com/counter/counter.js'></"+"script>");
</script>
<noscript><div class="statcounter"><a title="web analytics"
href="http://statcounter.com/" target="_blank"><img
class="statcounter"
src="http://c.statcounter.com/10446551/0/7320d794/1/"
alt="web analytics"></a></div></noscript>
<!-- End of StatCounter Code for Dreamweaver -->    
</body>
</html>